Podcasts by Category

Coronavirus (COVID-19) Q&A

Coronavirus (COVID-19) Q&A

JAMA Network

Conversations with experts and frontline clinicians about the COVID-19 pandemic, hosted by editors from the JAMA Network.

306 - Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy
0:00 / 0:00
1x
  • 306 - Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy

    Benjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as measured in surveys and administrative data. These differences have implications for estimating coverage now that the federal policy of continuous Medicaid eligibility during the COVID-19 pandemic has ended. Related Content:

    Survey-Reported Coverage in 2019-2022 and Implications for Unwinding Medicaid Continuous Eligibility
    Fri, 05 Apr 2024 - 19min
  • 305 - February 2024 Medical News Summary

    Rural Maternity Care Is in Crisis—Here’s What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds Related Content:

    More Than Half of US Rural Hospitals No Longer Offer Birthing Services—Here’s Why When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike
    Fri, 01 Mar 2024 - 13min
  • 304 - Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

    Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:

    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
    Tue, 06 Feb 2024 - 12min
  • 303 - Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

    The COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses how access to care and preventive services changed for different racial and ethnic groups in the US from 2019 to 2022. Related Content:

    Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity
    Fri, 02 Feb 2024 - 13min
  • 302 - Safety and Effectiveness of Maternal and Child COVID-19 Vaccination

    Two recent studies find that COVID-19 vaccination during pregnancy is safe for infants and effective for children aged 1-4 years. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, discuss clinical and policy implications with Grace Lee, MD, MPH, professor of Pediatrics at Stanford University School of Medicine, Palo Alto, California. Related Content:

    Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years
    Mon, 22 Jan 2024 - 20min
Show More Episodes